Table 1. Summary of clinicopathological characteristics of patients with HCC or ICC.

Characteristic	Tumor cases
	HCC	ICC	PLC*
Case number	64	18	82
Mean age (range)	54.2 (27–78)	52.6 (32–75)	53.9 (27–78)
Gender
Male	53 (82.8%)	14 (77.8%)	67 (81.7%)
Female	11 (17.2%)	4 (22.2%)	15 (18.3%)
Tumor stage
Stage 1	38 (59.4%)	4 (22.2%)	42 (51.2%)
Stage 1	26 (40.6%)	14 (77.8%)	40 (48.8%)
HBV infection
Positive	52 (81.3%)	12 (66.7%)	64 (78.1%)
Negative	12 (18.7%)	6 (33.3%)	18 (21.9%)
Differentiation
Well	10 (15.6%)	1 (5.5%)	11 (13.4%)
Moderate	38 (59.4%)	13 (72.2%)	51 (62.3%)
Poor	16 (25.0%)	4 (22.3%)	20 (24.3%)
NBS1 mutation
Yes	6 (9.4%)	2 (11.1%)	8 (9.8%)
No	58 (90.6%)	16 (88.9%)	74 (90.2%)

^* PLC: primary liver cancer.